Division of Translational Brain Sciences, Department of Neurology, Duke University Medical Center, Durham, NC 27710, USA.
Center for Genomic and Computational Biology, Duke University Medical Center, Durham, NC 27710, USA.
Hum Mol Genet. 2020 Nov 4;29(18):3107-3121. doi: 10.1093/hmg/ddaa183.
Alpha-synuclein SNCA has been implicated in the etiology of Parkinson's disease (PD); however, the normal function of alpha-synuclein protein and the pathway that mediates its pathogenic effect is yet to be discovered. We investigated the mechanistic role of SNCA in the nucleus utilizing isogenic human-induced pluripotent stem cells-derived neurons from PD patients with autosomal dominant mutations, A53T and SNCA-triplication, and their corresponding corrected lines by genome- and epigenome-editing. Comparisons of shape and integrity of the nuclear envelope and its resistance to stresses found that both mutations result in similar nuclear envelope perturbations that were reversed in the isogenic mutation-corrected cells. Further mechanistic studies showed that SNCA mutation has adverse effects on the nucleus by trapping Ras-related nuclear protein (RAN) and preventing it from transporting key nuclear proteins such as, DNMT3A, for maintaining normal nuclear function. For the first time, we proposed that α-syn interacts with RAN and normally functions in the nucleocytoplasmic transport while exerts its pathogenic effect by sequestering RAN. We suggest that defects in the nucleocytoplasmic transport components may be a general pathomechanistic driver of neurodegenerative diseases.
α-突触核蛋白(SNCA)已被牵连到帕金森病(PD)的病因中;然而,α-突触核蛋白的正常功能及其介导致病作用的途径仍有待发现。我们利用来自具有常染色体显性突变(A53T 和 SNCA-三重复)的 PD 患者的同源人诱导多能干细胞衍生神经元,以及通过基因组和表观基因组编辑的相应校正系,研究了 SNCA 在核内的机制作用。对核膜的形状和完整性及其对压力的抗性的比较发现,这两种突变都导致了类似的核膜扰动,而在同源突变校正细胞中则得到了逆转。进一步的机制研究表明,SNCA 突变通过捕获 Ras 相关核蛋白(RAN)并阻止其运输关键核蛋白(如 DNMT3A)来维持正常核功能,从而对核产生不利影响。我们首次提出,α-突触核蛋白与 RAN 相互作用,并在核质转运中正常发挥作用,同时通过隔离 RAN 来发挥其致病作用。我们认为,核质转运成分的缺陷可能是神经退行性疾病的一般病理机制驱动因素。